Physician profile
John M David
NPI 1538540117
$49,005.42
in general payments reported to CMS, 2019-2025
51 companies · $8,726 in 2025
The $8,726 reported for 2025 was more than what 96% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $174 · 2021: $441 · 2022: $5,863 · 2023: $16K · 2024: $17K · 2025: $8,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Honoraria: $7,842 · Food and Beverage: $6,092 · Travel and Lodging: $4,093 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,500.00 |
| Honoraria | $7,842.33 |
| Food and Beverage | $6,092.15 |
| Travel and Lodging | $4,092.59 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $39,699.30 | 2020-2025 | Gammatile, Gammatile |
| Siemens Medical Solutions USA, INC. | $3,454.19 | 2021-2024 | Bravos Afterloader System |
| Elekta, INC. | $634.49 | 2022-2025 | Elekta Medical Linear Accelerator |
| Bioprotect Medical, INC. | $460.75 | 2024-2025 | Bioprotect Balloon Implant System |
| Bayer Healthcare Pharmaceuticals INC. | $423.15 | 2020-2025 | |
| Reflexion Medical, INC. | $377.63 | 2022 | |
| Janssen Biotech, INC. | $295.47 | 2024-2025 | Erleada, Akeega, Darzalex |
| Novartis Pharmaceuticals Corporation | $288.15 | 2024-2025 | |
| Viewray Technologies INC | $279.79 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $254.64 | 2021-2025 | Imfinzi, Enhertu |
| Mevion_medical_systems_inc | $236.38 | 2021-2022 | |
| Incyte Corporation | $229.50 | 2024-2025 | Jakafi, Monjuvi |
| Teleflex LLC | $210.51 | 2025 | Barrigel |
| Boston Scientific Corporation | $173.24 | 2023-2025 | Spaceoar Vue System - 10ml |
| Tempus Ai, INC | $151.55 | 2024-2025 | Xt Cdx |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $149.54 | 2024-2025 | Enhertu, Datroway |
| Zap Surgical Systems, INC. | $137.10 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $124.92 | 2024-2025 | Libtayo |
| Springworks Therapeutics, INC. | $122.13 | 2024 | Ogsiveo |
| Ion Beam Applications S.A. | $110.62 | 2021 | |
| Sobi, INC | $103.09 | 2024-2025 | |
| Beigene USA, INC. | $99.54 | 2025 | Brukinsa |
| Novocure INC. | $96.18 | 2021-2025 | Optune Lua (Novottf-200t) |
| Merck Sharp & Dohme LLC | $93.46 | 2024-2025 | Keytruda, Welireg, Reblozyl |
| Eisai INC. | $75.09 | 2024-2025 | |
| Legend Biotech USA INC. | $70.76 | 2025 | Carvykti |
| Geron Corporation | $65.77 | 2025 | Rytelo |
| Aveo Pharmaceuticals, INC. | $58.89 | 2024-2025 | |
| Isoray, INC | $57.45 | 2022 | |
| Blue Earth Diagnostics | $56.27 | 2021-2022 | |
| Intuitive Surgical, INC. | $49.49 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.43 | 2025 | Iclusig |
| Glaxosmithkline, LLC. | $24.23 | 2025 | Jemperli, Zejula |
| Taiho Oncology, INC. | $23.96 | 2025 | |
| Azurity Pharmaceuticals, INC. | $23.00 | 2024 | Vivimusta |
| Astellas Pharma US INC | $21.23 | 2025 | Xtandi |
| Lilly USA, LLC | $21.19 | 2024 | Verzenio, Jaypirca, Retevmo |
| Sumitomo Pharma America, INC. | $19.91 | 2025 | Orgovyx |
| E.R. Squibb & Sons, L.L.C. | $19.66 | 2024 | Opdivo |
| Pharmacosmos Therapeutics INC. | $18.88 | 2025 | Monoferric |
| Cardinal Health 414 LLC | $18.86 | 2025 | |
| Brainlab, INC. | $17.02 | 2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Blueprint Medicines Corporation | $16.94 | 2025 | Ayvakit |
| Caris Mpi, INC. | $16.63 | 2025 | Mi Cancer Seek |
| Myriad Genetic Laboratories, INC. | $16.46 | 2021 | |
| Kyowa Kirin, INC. | $16.38 | 2024 | Poteligeo |
| Pfizer INC. | $16.15 | 2024 | |
| Exelixis INC. | $15.95 | 2024 | Cabometyx |
| Sirtex Medical INC | $14.93 | 2020 | |
| Puma Biotechnology, INC. | $14.57 | 2025 | Nerlynx |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.